Stock Watch: The Pandemic Brings Christmas Presents
Analyst Upgrades And Deferrals of Drug Pricing Legislation May Appear As Year-End Gifts
Executive Summary
While the Omicron variant does not bode well for 2022, vaccine boosters and oral antivirals are the products from the pharmaceutical sector that should keep on giving. Even if partisan analysts choose to forget them.